Nebulised 3% Hypertonic Saline
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Nebulised 3% Hypertonic Saline, covering 2024-08-16 to 2024-08-16. Get the full timeline:
Most recent: Clinical Trial Update: Nebulised 3% Hypertonic Saline in Infants With Acute Bronchiolitis [Phase 2, Phase 3]